Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)

NCT03941132 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Ustekinumab
DRUG: Placebo

Sponsor

University of British Columbia

Collaborators

[object Object]
[object Object]